My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 150

    1.

    NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment.

    Brewer HB Jr, Zech LA, Gregg RE, Schwartz D, Schaefer EJ.

    Ann Intern Med. 1983 May;98(5 Pt 1):623-40.PMID: 6846977 [PubMed - indexed for MEDLINE]Related articles

    2.

    Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia.

    Civeira F, Cenarro A, Ferrando J, Puzo J, Garcia-Otín AL, Mozas P, Pocoví M.

    Am Heart J. 1999 Jul;138(1 Pt 1):156-62.PMID: 10385780 [PubMed - indexed for MEDLINE]Related articles

    3.

    Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.

    Gregg RE, Ghiselli G, Brewer HB Jr.

    J Clin Endocrinol Metab. 1983 Nov;57(5):969-74.PMID: 6578216 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.

    Feussner G, Wagner A, Kohl B, Ziegler R.

    Clin Investig. 1993 May;71(5):362-6.PMID: 8508005 [PubMed - indexed for MEDLINE]Related articles

    5.

    Type III hyperlipoproteinemia with xanthomas and multiple myeloma.

    Burnside NJ, Alberta L, Robinson-Bostom L, Bostom A.

    J Am Acad Dermatol. 2005 Nov;53(5 Suppl 1):S281-4.PMID: 16227109 [PubMed - indexed for MEDLINE]Related articles

    6.

    Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.

    Feussner G, Albanese M, Mann WA, Valencia A, Schuster H.

    Eur J Clin Invest. 1996 Jan;26(1):13-23.PMID: 8682150 [PubMed - indexed for MEDLINE]Related articles

    7.

    Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.

    Ghiselli G, Schaefer EJ, Gascon P, Breser HB Jr.

    Science. 1981 Dec 11;214(4526):1239-41.PMID: 6795720 [PubMed - indexed for MEDLINE]Related articles

    8.

    Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2.

    Breslow JL, Zannis VI, SanGiacomo TR, Third JL, Tracy T, Glueck CJ.

    J Lipid Res. 1982 Nov;23(8):1224-35.PMID: 7175379 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins.

    Ishigami M, Yamashita S, Sakai N, Hirano K, Hiraoka H, Nakamura T, Matsuzawa Y.

    Atherosclerosis. 2003 Jun;168(2):359-66.PMID: 12801620 [PubMed - indexed for MEDLINE]Related articles

    10.

    Elevated concentrations of plasma lipids and apolipoproteins B, C-III, and E are associated with the progression of coronary artery disease in familial hypercholesterolemic swine.

    Hasler-Rapacz J, Prescott MF, Von Linden-Reed J, Rapacz JM Jr, Hu Z, Rapacz J.

    Arterioscler Thromb Vasc Biol. 1995 May;15(5):583-92.PMID: 7749872 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.

    Smelt AH, de Beer F.

    Semin Vasc Med. 2004 Aug;4(3):249-57. Review.PMID: 15630634 [PubMed - indexed for MEDLINE]Related articles

    12.

    Coexisting type III hyperlipoproteinemia and familial hypercholesterolemia: a case report.

    Sakuma N, Iwata S, Ikeuchi R, Ichikawa T, Hibino T, Kamiya Y, Ohte N, Kawaguchi M, Kunimatsu M, Kawahara H, et al.

    Metabolism. 1995 Apr;44(4):460-5.PMID: 7723668 [PubMed - indexed for MEDLINE]Related articles

    13.

    Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.

    Kypreos KE, Li X, van Dijk KW, Havekes LM, Zannis VI.

    Biochemistry. 2003 Aug 26;42(33):9841-53.PMID: 12924933 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III]

    Hagve TA, Furuset T, Christophersen B, Ose L.

    Tidsskr Nor Laegeforen. 1993 Mar 10;113(7):853-6. Norwegian. PMID: 8480294 [PubMed - indexed for MEDLINE]Related articles

    15.

    Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2/2 phenotype.

    Todo Y, Kobayashi J, Higashikata T, Kawashiri M, Nohara A, Inazu A, Koizumi J, Mabuchi H.

    Clin Chim Acta. 2004 Oct;348(1-2):35-40.PMID: 15369733 [PubMed - indexed for MEDLINE]Related articles

    16.

    Comparative effects of gemfibrozil and clofibrate in type III hyperlipoproteinemia.

    Larsen ML, Illingworth DR, O'Malley JP.

    Atherosclerosis. 1994 Apr;106(2):235-40.PMID: 8060383 [PubMed - indexed for MEDLINE]Related articles

    17.

    Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.

    Feussner G, Dobmeyer J, Nissen H, Hansen TS.

    Am J Med Genet. 1996 Oct 16;65(2):149-54.PMID: 8911609 [PubMed - indexed for MEDLINE]Related articles

    18.

    Apolipoprotein E2/E2 genotype in combination with mutations in the LDL receptor gene causes type III hyperlipoproteinemia.

    Geisel J, Bunte T, Bodis M, Oette K, Herrmann W.

    Clin Chem Lab Med. 2002 May;40(5):475-9.PMID: 12113291 [PubMed - indexed for MEDLINE]Related articles

    19.

    Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E.

    Gregg RE, Zech LA, Schaefer EJ, Brewer HB Jr.

    Science. 1981 Feb 6;211(4482):584-6.PMID: 7455696 [PubMed - indexed for MEDLINE]Related articles

    20.

    Long-term treatment of type III hyperlipoproteinemia with clofibrate.

    Stuyt PM, Demacker PN, Van't Laar A.

    Atherosclerosis. 1981 Nov-Dec;40(3-4):329-36.PMID: 7332612 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity